—

Travere Therapeutics Inc (TVTX) — the peer cohort

As of 2026-10-28 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Travere Therapeutics Inc ranks 7 of 7 in its cohort on the Closelooknet composite (42/100) — the cohort is led by BB Biotech AG at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
TVTX Travere Therapeutics Inc 42 61 28 10 info 26%
BION.SW BB Biotech AG 74 67 96 81 info 11.9%
HALO Halozyme Therapeutics Inc 73 98 94 38 ok 0.2%
UCB.BR UCB SA 65 66 70 53 info 6.1%
ARGX.BR Argen-X 64 75 75 29 info 13.9%
ONC BeiGene, Ltd. 64 85 64 30 ok 3.9%
ARGX argenx NV ADR 63 69 74 28 info 16.9%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-28

Quick answers

Who are Travere Therapeutics Inc's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: BB Biotech AG (BION.SW), Halozyme Therapeutics Inc (HALO), UCB SA (UCB.BR), Argen-X (ARGX.BR), BeiGene, Ltd. (ONC), argenx NV ADR (ARGX).

How does TVTX score against its peers?

Travere Therapeutics Inc's composite reads 42/100, ranking 7 of 7 in its cohort as of 2026-10-28; the cohort's highest composite is BB Biotech AG at 74/100. Closelooknet scores are research diary readings, not ratings or advice.

Mentioned on Closelooknet

Where TVTX appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.